Literature DB >> 25750247

Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention.

Richard J Drake1, Merete Nordentoft2, Gillian Haddock3, Celso Arango4, W Wolfgang Fleischhacker5, Birte Glenthøj6, Marion Leboyer7, Stefan Leucht8, Markus Leweke9, Phillip McGuire10, Andreas Meyer-Lindenberg9, Dan Rujescu11, Iris E Sommer12, René S Kahn12, Shon W Lewis13.   

Abstract

We aimed to design a multimodal intervention to improve adherence following first episode psychosis, consistent with current evidence. Existing literature identified medication attitudes, insight, and characteristics of support as important determinants of adherence to medication: we examined medication attitudes, self-esteem, and insight in an early psychosis cohort better to understand their relationships. Existing longitudinal data from 309 patients with early Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, nonaffective psychosis (83% first episode) were analyzed to test the hypothesis that medication attitudes, while meaningfully different from "insight," correlated with insight and self-esteem, and change in each influenced the others. Rosenberg Self-Esteem Scale, Birchwood Insight Scale, and Positive and Negative Syndrome Scale insight were assessed at presentation, after 6 weeks and 3 and 18 months. Drug Attitudes Inventory (DAI) and treatment satisfaction were rated from 6 weeks onward. Structural equation models of their relationships were compared. Insight measures' and DAI's predictive validity were compared against relapse, readmission, and remission. Analysis found five latent constructs best fitted the data: medication attitudes, self-esteem, accepting need for treatment, self-rated insight, and objective insight. All were related and each affected the others as it changed, except self-esteem and medication attitudes. Low self-reported insight at presentation predicted readmission. Good 6-week insight (unlike drug attitudes) predicted remission. Literature review and data modeling indicated that a multimodal intervention using motivational interviewing, online psychoeducation, and SMS text medication reminders to enhance adherence without damaging self-concept was feasible and appropriate.
© The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  adherence; first episode; insight; mHealth; schizophrenia; self-esteem; web-based

Mesh:

Year:  2015        PMID: 25750247      PMCID: PMC4393703          DOI: 10.1093/schbul/sbv015

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  119 in total

1.  Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects.

Authors:  H Verdoux; J Lengronne; F Liraud; B Gonzales; F Assens; F Abalan; J van Os
Journal:  Acta Psychiatr Scand       Date:  2000-09       Impact factor: 6.392

Review 2.  Interventions to improve medication adherence in schizophrenia.

Authors:  Annette Zygmunt; Mark Olfson; Carol A Boyer; David Mechanic
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

3.  Early insight predicts depression and attempted suicide after 4 years in first-episode schizophrenia and schizophreniform disorder.

Authors:  N Crumlish; P Whitty; M Kamali; M Clarke; S Browne; O McTigue; A Lane; A Kinsella; C Larkin; E O'Callaghan
Journal:  Acta Psychiatr Scand       Date:  2005-12       Impact factor: 6.392

Review 4.  Behavior change interventions delivered by mobile telephone short-message service.

Authors:  Brianna S Fjeldsoe; Alison L Marshall; Yvette D Miller
Journal:  Am J Prev Med       Date:  2009-02       Impact factor: 5.043

5.  Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.

Authors:  Eva-Marina Beck; Marialuisa Cavelti; Sara Kvrgic; Birgit Kleim; Roland Vauth
Journal:  Schizophr Res       Date:  2011-08-05       Impact factor: 4.939

6.  Is living with psychosis demoralizing? Insight, self-stigma, and clinical outcome among people with schizophrenia across 1 year.

Authors:  Marialuisa Cavelti; Nicolas Rüsch; Roland Vauth
Journal:  J Nerv Ment Dis       Date:  2014-07       Impact factor: 2.254

7.  Antipsychotic long-acting injections: mind the gap.

Authors:  Maxine X Patel; Mark Taylor; Anthony S David
Journal:  Br J Psychiatry Suppl       Date:  2009-11

8.  Stigma moderates the associations of insight with depressed mood, low self-esteem, and low quality of life in patients with schizophrenia spectrum disorders.

Authors:  A B P Staring; M Van der Gaag; M Van den Berge; H J Duivenvoorden; C L Mulder
Journal:  Schizophr Res       Date:  2009-07-17       Impact factor: 4.939

9.  Health beliefs link to duration of untreated psychosis and attitudes to later treatment in early psychosis.

Authors:  C J Haley; R J Drake; R P Bentall; S W Lewis
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2003-06       Impact factor: 4.328

Review 10.  Information and communication technology in patient education and support for people with schizophrenia.

Authors:  Maritta Välimäki; Heli Hätönen; Mari Lahti; Lauri Kuosmanen; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17
View more
  11 in total

1.  Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms.

Authors:  J-G Daneault; A Maraj; M Lepage; A Malla; N Schmitz; S N Iyer; R Joober; J L Shah
Journal:  Acta Psychiatr Scand       Date:  2019-04       Impact factor: 6.392

2.  Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments.

Authors:  Paul H Lysaker; Michelle L Pattison; Bethany L Leonhardt; Scott Phelps; Jenifer L Vohs
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

Review 3.  Mobile Phone Ownership and Endorsement of "mHealth" Among People With Psychosis: A Meta-analysis of Cross-sectional Studies.

Authors:  Joseph Firth; Jack Cotter; John Torous; Sandra Bucci; Josh A Firth; Alison R Yung
Journal:  Schizophr Bull       Date:  2015-09-22       Impact factor: 9.306

4.  Characteristics associated with self-reported medication adherence in persons with psychosis referred to psychosocial rehabilitation centers.

Authors:  Hélène Verdoux; Clélia Quiles; Laura Bon; Isabelle Chéreau-Boudet; Julien Dubreucq; Emilie Legros-Lafarge; Nathalie Guillard-Bouhet; Catherine Massoubre; Julien Plasse; Nicolas Franck
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-11-10       Impact factor: 5.270

5.  Investigating the efficacy of an individualized metacognitive therapy program (MCT+) for psychosis: study protocol of a multi-center randomized controlled trial.

Authors:  Brooke C Schneider; Martin Brüne; Francesca Bohn; Ruth Veckenstedt; Katharina Kolbeck; Eva Krieger; Anna Becker; Kim Alisha Drommelschmidt; Susanne Englisch; Sarah Eisenacher; Sie-In Lee-Grimm; Matthias Nagel; Mathias Zink; Steffen Moritz
Journal:  BMC Psychiatry       Date:  2016-02-27       Impact factor: 3.630

6.  Factors affecting medication adherence in children receiving outpatient pharmacotherapy and parental adherence.

Authors:  Masaharu Nagae; Hideyuki Nakane; Sumihisa Honda; Hiroki Ozawa; Hiroko Hanada
Journal:  J Child Adolesc Psychiatr Nurs       Date:  2015-05

7.  Mindfulness-based social cognition training (SocialMIND) versus psychoeducational multicomponent intervention for people with a first episode of psychosis: a study protocol for a randomised controlled trial.

Authors:  Roberto Mediavilla; Ainoa Muñoz-Sanjose; Beatriz Rodriguez-Vega; Carmen Bayon; Angela Palao; Guillermo Lahera; Pilar Sanchez-Castro; Eva Roman; Susana Cebolla; Alvaro de Diego; Juan Manuel Pastor; Maria Fe Bravo-Ortiz
Journal:  BMC Psychiatry       Date:  2019-07-29       Impact factor: 3.630

8.  Neurocognitive and clinical correlates of insight in schizophrenia.

Authors:  Dhanya Raveendranathan; Jessie Joseph; Tanya Machado; Ashok Mysore
Journal:  Indian J Psychiatry       Date:  2020-03-17       Impact factor: 1.759

9.  The association between insight and depressive symptoms in schizophrenia: Undirected and Bayesian network analyses.

Authors:  Mario Amore; Martino Belvederi Murri; Pietro Calcagno; Paola Rocca; Alessandro Rossi; Eugenio Aguglia; Antonello Bellomo; Giuseppe Blasi; Bernardo Carpiniello; Alessandro Cuomo; Liliana dell'Osso; Massimo di Giannantonio; Giulia Maria Giordano; Carlo Marchesi; Palmiero Monteleone; Cristiana Montemagni; Lucio Oldani; Maurizio Pompili; Rita Roncone; Rodolfo Rossi; Alberto Siracusano; Antonio Vita; Patrizia Zeppegno; Alessandro Corso; Costanza Arzani; Silvana Galderisi; Mario Maj
Journal:  Eur Psychiatry       Date:  2020-05-06       Impact factor: 5.361

Review 10.  Is It Possible to Predict the Future in First-Episode Psychosis?

Authors:  Jaana Suvisaari; Outi Mantere; Jaakko Keinänen; Teemu Mäntylä; Eva Rikandi; Maija Lindgren; Tuula Kieseppä; Tuukka T Raij
Journal:  Front Psychiatry       Date:  2018-11-13       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.